News

September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.

Home September 19, 2007
Home
News

September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.

Home September 18, 2007
Home
News

September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and ...

Home September 18, 2007
Home
News

September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the ...

Home September 18, 2007
Home
News

September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.

Home September 18, 2007
Home
News

September 19, 2007 - For patients with equivocal or discordant findings on myocardial perfusion imaging, CT angiography ...

Home September 18, 2007
Home
News

September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) ...

Home September 18, 2007
Home
News

September 19, 2007 - Risk stratification using single-photon emission computed tomography (SPECT) led to shorter stays ...

Home September 18, 2007
Home
News

September 18, 2007 – CardioDynamics, an impedance cardiography (ICG) technology developer, announced plans to accelerate ...

Home September 17, 2007
Home
News

September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & ...

Home September 17, 2007
Home
News

September 18, 2007 - Forty-one U.S. hospitals have been named 2007 Leapfrog Top Hospitals, based on results from the ...

Home September 17, 2007
Home
News

September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all ...

Home September 17, 2007
Home
News

September 18, 2007 - Vasogen Inc. announced plans for a confirmatory study of its Celacade technology for the treatment ...

Home September 17, 2007
Home
News

September 18, 2007 - Baseline data from the largest study of U.S.-based heart failure (HF) patients in the outpatient ...

Home September 17, 2007
Home
News

September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.

Home September 17, 2007
Home
Subscribe Now